You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-HRAS (HRAS) Antibodies

Full name:
anti-V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog Antibodies (HRAS)
On www.antibodies-online.com are 134 V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Antibodies from 25 different suppliers available. Additionally we are shipping HRAS Proteins (19) and HRAS Kits (14) and many more products for this protein. A total of 176 HRAS products are currently listed.
Synonyms:
AI929937, C-BAS/HAS, c-H-ras, c-Ha-ras, C-HA-RAS1, c-rasHa, CTLO, H-ras, H-RASIDX, Ha-ras, HAMSV, Harvey-ras, hras, Hras-1, HRAS1, K-ras, Ki-ras, Kras-2, Kras2, N-RAS, p21B, ras, RASH1, zgc:110250

Most Popular Reactivities for anti-HRAS (HRAS) Antibodies

Select your species and application

anti-Human HRAS Antibodies:

anti-Rat (Rattus) HRAS Antibodies:

anti-Mouse (Murine) HRAS Antibodies:

All available anti-HRAS Antibodies

Go to our pre-filtered search.

Top referenced anti-HRAS Antibodies

  1. Human Polyclonal HRAS Primary Antibody for EIA, IF - ABIN952792 : Ma, Liu, Wu, Terada: p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. in Oncogene 2010 (PubMed)
    Show all 5 references for ABIN952792

  2. Human Monoclonal HRAS Primary Antibody for EIA, WB - ABIN238418 : Prior, Harding, Yan, Sluimer, Parton, Hancock: GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. in Nature cell biology 2001 (PubMed)
    Show all 5 references for ABIN238418

  3. Human Polyclonal HRAS Primary Antibody for IF, WB - ABIN655622 : van Engen-van Grunsven, van Dijk, Ruiter, Klaasen, Mooi, Blokx: HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. in The American journal of surgical pathology 2010 (PubMed)
    Show all 4 references for ABIN655622

  4. Human Polyclonal HRAS Primary Antibody for EIA, WB - ABIN360066 : Coats, Booden, Buss: Transient palmitoylation supports H-Ras membrane binding but only partial biological activity. in Biochemistry 1999 (PubMed)
    Show all 3 references for ABIN360066

  5. Human Polyclonal HRAS Primary Antibody for IF, IHC (p) - ABIN392183 : Maemoto, Yumoto, Ibata, Torizuka, Ozawa, Tatsumi, Hashido, Morikawa, Maeda, Imai: Mutational analysis of HRAS and KRAS genes in oral carcinoma cell lines. in Odontology / the Society of the Nippon Dental University 2012 (PubMed)
    Show all 2 references for ABIN392183

More Antibodies against HRAS Interaction Partners

Cow (Bovine) V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) interaction partners

  1. Data demonstrate that H-Ras activation is important in the activation of the specific signaling events leading to the accelerated retinal capillary cell apoptosis in hyperglycemic conditions.

  2. Activation of H-Ras and its downstream signaling pathway in the retina and its vasculature could be under the control of superoxide, and H-Ras activation in diabetes can be prevented by inhibiting superoxide accumulation.

  3. Thrombospondin 1 (show THBS1 Antibodies), fibronectin (show FN1 Antibodies), and vitronectin (show VTN Antibodies) are differentially dependent upon RAS, ERK1/2 (show MAPK1/3 Antibodies), and p38 (show MAPK14 Antibodies) for induction of vascular smooth muscle cell chemotaxis.

Zebrafish V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) interaction partners

  1. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish

Human V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) interaction partners

  1. HRAS mutation is associated in children with delayed puberty and probably with precocious puberty.

  2. HRAS mutation is associated with salivary duct carcinoma.

  3. Impact of SNPs on CpG Islands in the MYC (show MYC Antibodies) and HRAS oncogenes and in a wide variety of tumor suppressor genes has been analyzed in a multi-cancer bioinformatics approach.

  4. Ras isoforms' dimer conformations are not uniform; instead, the isoform-specific dimers reflect the favoured interactions of the HVRs (hypervariable regions) with cell membrane microdomains, biasing the effector-binding site orientations, thus isoform binding selectivity.

  5. Two unrelated boys with Costello syndrome and an HRAS mutation (p.Gly13Cys) are presented with their ophthalmologic findings. Both had early symptoms of nystagmus, photophobia, and vision abnormalities

  6. The fact that no malignant tumors were described in these individuals does not allow definitive conclusions about the risk for cancer development. It remains to be determined if substitutions of amino acid 13 in HRAS (p.Gly13Asp and p.Gly13Cys) increase the risk of tumor development

  7. herefore, our results also demonstrate that the phenotype in CS and somatic cancers is not only determined by the different transforming potentials of mutant HRAS proteins, but also by the efficiency of exon 2 inclusion resulting from the different HRAS mutations.

  8. Point mutations of HRAS is associated with thyroid cancer.

  9. The results show that mutant RAS is associated with an earlier and higher rate of local tumour progression in patients undergoing ablation of CLMs.

  10. A report of three cases with pediatric urothelial bladder cancer indicates that the tumors are characterized by a consistent H-RAS mutation status, whereas FGFR3 (show FGFR3 Antibodies) and p53 (show TP53 Antibodies) pathways are not involved in this tumor initiation.

Mouse (Murine) V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) interaction partners

  1. loss of one allele of Hras increased the sensitivity of mice to this carcinogen, and this effect was further exacerbated by the loss of the second Hras allele. However, loss of one or both alleles of Nras (show NRAS Antibodies) failed to alter tumor burden, either in the absence or presence of Hras, after exposure to urethane.

  2. H-ras isoform mediates protection against pressure overload-induced cardiac dysfunction in part through activation of AKT (show AKT1 Antibodies)/PI3K signaling pathway.

  3. KRAS K104Q mutant exhibited defects in both guanine nucleotide exchange factors -mediated exchange and GTPase-activating proteins -mediated GTP hydrolysis, consistent with NMR-detected structural perturbations in localized regions of KRAS important for recognition of these regulatory proteins.

  4. farnesylation of K-Ras was required for its packaging within extracellular nanovesicles, yet expressing a K-Ras farnesylation mutant did not decrease the number of nanovesicles or the amount of Alix (show PDCD6IP Antibodies) protein released per cell.

  5. The K-Ras(V14I) activating protein is able to induce cancer, although at a much lower level than the classical K-Ras(G12V) oncogene (show RAB1A Antibodies), and that it can be significantly modulated by both genetic and non-genetic events.

  6. The long intergenic non-coding RNA CCR492 functions as a let-7 competitive endogenous RNA to de-repress c-Myc (show MYC Antibodies) expression and to promote cell transformation assisted by the constitutively active H-Ras.

  7. Gli1 and Gli2 exhibited different functions in the regulation of p63 expression or proliferation of p63(+) cells in Kras-AR driven tumors.

  8. these contrasting signatures precisely match those proposed to confer bias toward Hras(CAA61CTA) versus Braf (show BRAF Antibodies)(GTG636GAG) mutations in the original tumor sets. Our findings highlight a novel mechanism whereby exposure history acts through strand-biased mutagenesis to specify activation of preferred oncogenes

  9. our data suggest that GGPPS is essential for maintaining fetal lung branching morphogenesis, which is possibly through regulating K-Ras prenylation.

  10. We establishment the transgenic mouse model of K-ras(G12D) p53 (show TP53 Antibodies)(loxP/loxP) and found that K-ras mutation and p53 (show TP53 Antibodies) deletion within the ovarian surface epithelium gave rise to ovarian lesions with a hyperproliferation and endometrioid glandular morphology

HRAS Antigen Profile

Antigen Summary

This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, mental retardation, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.

Alternative names and synonyms associated with HRAS

  • Harvey rat sarcoma viral oncogene homolog (hras) antibody
  • v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) antibody
  • v-Ha-ras Harvey rat sarcoma viral oncogene homolog a (hrasa) antibody
  • neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS) antibody
  • v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) antibody
  • Harvey rat sarcoma viral oncogene homolog (HRAS) antibody
  • Harvey rat sarcoma virus oncogene (Hras) antibody
  • Harvey rat sarcoma virus oncogene 1 (Hras1) antibody
  • v-Ha-ras Harvey rat sarcoma viral oncogene homolog (Hras) antibody
  • v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras) antibody
  • AI929937 antibody
  • C-BAS/HAS antibody
  • c-H-ras antibody
  • c-Ha-ras antibody
  • C-HA-RAS1 antibody
  • c-rasHa antibody
  • CTLO antibody
  • H-ras antibody
  • H-RASIDX antibody
  • Ha-ras antibody
  • HAMSV antibody
  • Harvey-ras antibody
  • hras antibody
  • Hras-1 antibody
  • HRAS1 antibody
  • K-ras antibody
  • Ki-ras antibody
  • Kras-2 antibody
  • Kras2 antibody
  • N-RAS antibody
  • p21B antibody
  • ras antibody
  • RASH1 antibody
  • zgc:110250 antibody

Protein level used designations for HRAS

v-Ha-ras Harvey rat sarcoma viral oncogene homolog , small G-protein H-Ras , Harvey ras 1 , p19 H-RasIDX protein , GTPase HRas (Transforming protein p21) (H-Ras-1) (c-H-ras) , xRAS1 , GTPase HRas , Transforming protein p21 , neuroblastoma ras oncogene , GTP- and GDP-binding peptide B , H-Ras-1 , Ha-Ras1 proto-oncoprotein , Ras family small GTP binding protein H-Ras , c-has/bas p21 protein , c-ras-Ki-2 activated oncogene , p21ras , transformation gene: oncogene HAMSV , transforming protein p21 , Harvey ras1 protein , Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog , H-ras 1 protein , c-Ha-ras p21 protein , c-Ha-ras transgene , transforming protein P21 , GTPase NRas , transforming protein N-Ras , c-H-ras , v-Ha-ras Harvey rat sarcoma viral oncogene-like protein , ras p21 , GTPase KRas , K-Ras 2 , Kirsten rat sarcoma oncogene 2, expressed , c-K-ras , c-Ki-ras , p21 protein

GENE ID SPECIES
399406 Xenopus laevis
466302 Pan troglodytes
513012 Bos taurus
549757 Xenopus (Silurana) tropicalis
550286 Danio rerio
698830 Macaca mulatta
733587 Sus scrofa
100222058 Taeniopygia guttata
100227892 Taeniopygia guttata
3265 Homo sapiens
293621 Rattus norvegicus
15461 Mus musculus
100739349 Sus scrofa
100735038 Cavia porcellus
396229 Gallus gallus
403735 Canis lupus familiaris
100298939 Bos taurus
101104357 Ovis aries
16653 Mus musculus
Selected quality suppliers for anti-HRAS (HRAS) Antibodies
Did you look for something else?